Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) Stock Price

TEVAStock

$38.10+11.38%52W

Market Cap$44.40B

P/E30.52x

PEG Ratio1.02

Div yield—

Beta0.47

TEVA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-0.75%

Price vs S&P 500 (4W)12.10%

PEG Ratio1.02

VGM Score50.57

P/E Ratio (Annual)30.52x

P/CF (Annual)26.11x

Book Value / Share (Quarterly)$6.66

P/TBV (Annual)9.38x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)4.96%

Cash Flow / Share (Quarterly)$1.16

Price vs S&P 500 (YTD)-1.81%

Gross Margin (TTM)52.86%

Net Profit Margin (TTM)4.09%

EPS (TTM)$0.60

10-Day Avg Trading Volume0.73M

EPS Excl Extra (TTM)$0.60

Revenue Growth (5Y)0.71%

EPS (Annual)$1.21

ROI (Annual)5.71%

Gross Margin (Annual)52.87%

Net Profit Margin (5Y Avg)-3.80%

Cash / Share (Quarterly)$3.14

P/E Basic Excl Extra (TTM)60.73x

Revenue Growth QoQ (YoY)-0.81%

P/E Normalized (Annual)30.52x

ROA (Last FY)3.46%

Revenue Growth TTM (YoY)4.13%

EBITD / Share (TTM)$2.02

ROE (5Y Avg)-9.48%

Operating Margin (TTM)9.26%

Cash Flow / Share (Annual)$1.00

P/B Ratio5.55x

P/B Ratio (Quarterly)4.95x

Net Income / Employee (Annual)$45,300

EV / Revenue (TTM)3.23x

Net Interest Coverage (TTM)2.41x

ROA (TTM)1.77%

EPS Growth QoQ (YoY)67.39%

EV / EBITDA (TTM)23.74x

EPS Incl Extra (Annual)$1.21

Current Ratio (Annual)1.04x

Quick Ratio (Quarterly)0.61x

3-Month Avg Trading Volume1.15M

52-Week Price Return11.38%

EV / Free Cash Flow (Annual)48.78x

P/E Incl Extra (TTM)60.73x

Revenue / Employee (TTM)$555,400

Tangible BV / Share (Quarterly)$3.70

P/S Ratio (Annual)2.50x

Asset Turnover (Annual)0.42x

52-Week High$11350.00

Operating Margin (5Y Avg)1.90%

EPS Excl Extra (Annual)$1.21

CapEx CAGR (5Y)-2.82%

Tangible BV CAGR (5Y)30.21%

26-Week Price Return11.39%

Quick Ratio (Annual)0.72x

13-Week Price Return3.45%

Total Debt / Equity (Annual)2.12x

Current Ratio (Quarterly)0.88x

Enterprise Value$56.00B

Revenue / Share Growth (5Y)-0.50%

Asset Turnover (TTM)0.43x

Book Value / Share Growth (5Y)-5.53%

Revenue / Employee (Annual)$553,600

Inventory Turnover (Annual)2.63x

Pretax Margin (Annual)7.09%

Cash / Share (Annual)$3.09

3-Month Return Std Dev40.70%

Gross Margin (5Y Avg)50.54%

Net Income / Employee (TTM)$22,700

EBITDA Interim CAGR (5Y)14.09%

ROE (Last FY)17.84%

Net Interest Coverage (Annual)1.79x

EPS Basic Excl Extra (Annual)$1.21

P/FCF (TTM)27.67x

Receivables Turnover (TTM)4.91x

EV / Free Cash Flow (TTM)41.54x

Total Debt / Equity (Quarterly)2.14x

EPS Incl Extra (TTM)$0.60

Receivables Turnover (Annual)5.10x

ROI (TTM)2.90%

P/S Ratio (TTM)2.49x

Pretax Margin (5Y Avg)-4.33%

Revenue / Share (Annual)$14.84

Tangible BV / Share (Annual)$3.59

Forward P/E13.28x

Free OCF CAGR (5Y)12.47%

Price vs S&P 500 (52W)17.87%

P/E Ratio (TTM)60.73x

Year-to-Date Return9.91%

5-Day Price Return0.09%

EPS Normalized (Annual)$1.21

ROA (5Y Avg)-1.34%

Net Profit Margin (Annual)8.18%

Month-to-Date Return2.02%

Cash Flow / Share (TTM)$-3.69

EBITD / Share (Annual)$2.72

Operating Margin (Annual)12.50%

LT Debt / Equity (Annual)1.89x

P/CF (TTM)22.67x

ROI (5Y Avg)-2.12%

P/E Excl Extra (TTM)60.73x

LT Debt / Equity (Quarterly)1.56x

EPS Basic Excl Extra (TTM)$0.60

P/TBV (Quarterly)8.92x

P/B Ratio (Annual)4.90x

Inventory Turnover (TTM)2.43x

Pretax Margin (TTM)4.09%

Book Value / Share (Annual)$6.88

Price vs S&P 500 (13W)0.15%

Beta0.47x

P/FCF (Annual)37.51x

Revenue / Share (TTM)$14.86

ROE (TTM)9.11%

52-Week Low$5966.00

vGradeC

gGradeC

mGradeC

vgmGradeC

TEVA Earnings Surprise History

Q2 250.66est. 0.62

Q3 250.78est. 0.67

Q4 250.96est. 0.64

Q1 260.53est. 0.46

Q2 260.02est. 0.11

TEVA Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.14

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$67.01

About Teva Pharmaceutical Industries Limited American Depositary Shares

Teva is the world's leading generic pharmaceutical manufacturer, with approximately half its revenue derived from North America where it captures a high single-digit percentage of US generic prescriptions. Beyond generics, the Israel-based company operates a specialty portfolio including innovative medicines and biosimilars across central nervous system, respiratory, and oncology therapeutic areas. Teva also generates revenue through active pharmaceutical ingredients, contract manufacturing, and Anda, its US-based generic and specialty drug distributor.